nodes	percent_of_prediction	percent_of_DWPC	metapath
Mesoridazine—HTR6—Amine ligand-binding receptors—TAAR6—cervical cancer	0.064	0.064	CbGpPWpGaD
Mesoridazine—DRD3—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0544	0.0544	CbGpPWpGaD
Mesoridazine—HTR1A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0474	0.0474	CbGpPWpGaD
Mesoridazine—HTR2C—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0471	0.0471	CbGpPWpGaD
Mesoridazine—DRD2—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0416	0.0416	CbGpPWpGaD
Mesoridazine—HTR2A—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0409	0.0409	CbGpPWpGaD
Mesoridazine—HRH1—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0408	0.0408	CbGpPWpGaD
Mesoridazine—CHRM2—Amine ligand-binding receptors—TAAR6—cervical cancer	0.0402	0.0402	CbGpPWpGaD
Mesoridazine—HTR2A—Serotonin Receptor 2 and STAT3 Signaling—STAT3—cervical cancer	0.0392	0.0392	CbGpPWpGaD
Mesoridazine—HTR6—G alpha (s) signalling events—TAAR6—cervical cancer	0.0264	0.0264	CbGpPWpGaD
Mesoridazine—KCNH2—Hematopoietic Stem Cell Differentiation—NOTCH1—cervical cancer	0.0198	0.0198	CbGpPWpGaD
Mesoridazine—HTR6—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0126	0.0126	CbGpPWpGaD
Mesoridazine—DRD3—Circadian rythm related genes—UBE3A—cervical cancer	0.0117	0.0117	CbGpPWpGaD
Mesoridazine—DRD3—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.0107	0.0107	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—TAAR6—cervical cancer	0.00959	0.00959	CbGpPWpGaD
Mesoridazine—HTR1A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00932	0.00932	CbGpPWpGaD
Mesoridazine—HTR2C—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00927	0.00927	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—UBE3A—cervical cancer	0.00897	0.00897	CbGpPWpGaD
Mesoridazine—KCNH2—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00883	0.00883	CbGpPWpGaD
Mesoridazine—DRD2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00818	0.00818	CbGpPWpGaD
Mesoridazine—DRD3—GPCR ligand binding—TAAR6—cervical cancer	0.00814	0.00814	CbGpPWpGaD
Mesoridazine—HTR2A—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00805	0.00805	CbGpPWpGaD
Mesoridazine—HRH1—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00803	0.00803	CbGpPWpGaD
Mesoridazine—CHRM2—Class A/1 (Rhodopsin-like receptors)—TAAR6—cervical cancer	0.00791	0.00791	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—WNT2—cervical cancer	0.00748	0.00748	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—TAAR6—cervical cancer	0.0071	0.0071	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—TAAR6—cervical cancer	0.00706	0.00706	CbGpPWpGaD
Mesoridazine—DRD3—GPCR ligand binding—WNT2—cervical cancer	0.00636	0.00636	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—TAAR6—cervical cancer	0.00623	0.00623	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—TAAR6—cervical cancer	0.00613	0.00613	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—TAAR6—cervical cancer	0.00612	0.00612	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—TAAR6—cervical cancer	0.00602	0.00602	CbGpPWpGaD
Mesoridazine—HTR6—GPCR ligand binding—WNT5A—cervical cancer	0.00567	0.00567	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—WNT2—cervical cancer	0.00554	0.00554	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00554	0.00554	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—WNT2—cervical cancer	0.00551	0.00551	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—TAAR6—cervical cancer	0.00542	0.00542	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—TAAR6—cervical cancer	0.00492	0.00492	CbGpPWpGaD
Mesoridazine—HRH1—IL-4 Signaling Pathway—STAT3—cervical cancer	0.00488	0.00488	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—WNT2—cervical cancer	0.00486	0.00486	CbGpPWpGaD
Mesoridazine—DRD3—GPCR ligand binding—WNT5A—cervical cancer	0.00482	0.00482	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—WNT2—cervical cancer	0.00479	0.00479	CbGpPWpGaD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—HES1—cervical cancer	0.00478	0.00478	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—WNT2—cervical cancer	0.00478	0.00478	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—WNT2—cervical cancer	0.0047	0.0047	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—HES1—cervical cancer	0.0047	0.0047	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—TAAR6—cervical cancer	0.0046	0.0046	CbGpPWpGaD
Mesoridazine—KCNH2—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00459	0.00459	CbGpPWpGaD
Mesoridazine—KCNH2—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00443	0.00443	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR ligand binding—WNT5A—cervical cancer	0.0042	0.0042	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—TAAR6—cervical cancer	0.00418	0.00418	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR ligand binding—WNT5A—cervical cancer	0.00418	0.00418	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—TAAR6—cervical cancer	0.00401	0.00401	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—TAAR6—cervical cancer	0.00399	0.00399	CbGpPWpGaD
Mesoridazine—CHRM2—Regulation of Actin Cytoskeleton—FGFR3—cervical cancer	0.00392	0.00392	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—WNT2—cervical cancer	0.00384	0.00384	CbGpPWpGaD
Mesoridazine—HTR6—GPCR downstream signaling—AKAP13—cervical cancer	0.00371	0.00371	CbGpPWpGaD
Mesoridazine—DRD2—GPCR ligand binding—WNT5A—cervical cancer	0.00369	0.00369	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—TAAR6—cervical cancer	0.00364	0.00364	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR ligand binding—WNT5A—cervical cancer	0.00363	0.00363	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—TAAR6—cervical cancer	0.00362	0.00362	CbGpPWpGaD
Mesoridazine—HRH1—GPCR ligand binding—WNT5A—cervical cancer	0.00362	0.00362	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR ligand binding—WNT5A—cervical cancer	0.00356	0.00356	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—TAAR6—cervical cancer	0.00352	0.00352	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—TAAR6—cervical cancer	0.00346	0.00346	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—TAAR6—cervical cancer	0.00346	0.00346	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—TAAR6—cervical cancer	0.0034	0.0034	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—AKAP13—cervical cancer	0.00337	0.00337	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—WNT2—cervical cancer	0.00326	0.00326	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—TAAR6—cervical cancer	0.0032	0.0032	CbGpPWpGaD
Mesoridazine—DRD3—GPCR downstream signaling—AKAP13—cervical cancer	0.00315	0.00315	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—TAAR6—cervical cancer	0.00315	0.00315	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—TAAR6—cervical cancer	0.00314	0.00314	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—TAAR6—cervical cancer	0.00309	0.00309	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—WNT5A—cervical cancer	0.00291	0.00291	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TAAR6—cervical cancer	0.00291	0.00291	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00288	0.00288	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—AKAP13—cervical cancer	0.00286	0.00286	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—WNT2—cervical cancer	0.00284	0.00284	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—WNT2—cervical cancer	0.00283	0.00283	CbGpPWpGaD
Mesoridazine—HTR1A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00278	0.00278	CbGpPWpGaD
Mesoridazine—HTR1A—GPCR downstream signaling—AKAP13—cervical cancer	0.00275	0.00275	CbGpPWpGaD
Mesoridazine—HTR2C—GPCR downstream signaling—AKAP13—cervical cancer	0.00273	0.00273	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—WNT2—cervical cancer	0.0025	0.0025	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—AKAP13—cervical cancer	0.0025	0.0025	CbGpPWpGaD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00249	0.00249	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—AKAP13—cervical cancer	0.00248	0.00248	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—WNT5A—cervical cancer	0.00247	0.00247	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TAAR6—cervical cancer	0.00247	0.00247	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—WNT2—cervical cancer	0.00246	0.00246	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—WNT2—cervical cancer	0.00245	0.00245	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—CASP3—cervical cancer	0.00244	0.00244	CbGpPWpGaD
Mesoridazine—DRD2—GPCR downstream signaling—AKAP13—cervical cancer	0.00241	0.00241	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—WNT2—cervical cancer	0.00241	0.00241	CbGpPWpGaD
Mesoridazine—HTR2A—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.0024	0.0024	CbGpPWpGaD
Mesoridazine—HTR2A—GPCR downstream signaling—AKAP13—cervical cancer	0.00237	0.00237	CbGpPWpGaD
Mesoridazine—HRH1—GPCR downstream signaling—AKAP13—cervical cancer	0.00237	0.00237	CbGpPWpGaD
Mesoridazine—CHRM2—SIDS Susceptibility Pathways—CTNNB1—cervical cancer	0.00236	0.00236	CbGpPWpGaD
Mesoridazine—CHRM2—GPCR downstream signaling—AKAP13—cervical cancer	0.00233	0.00233	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—WNT2—cervical cancer	0.00227	0.00227	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—AKAP13—cervical cancer	0.00219	0.00219	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—AKAP13—cervical cancer	0.00216	0.00216	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—WNT5A—cervical cancer	0.00215	0.00215	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—AKAP13—cervical cancer	0.00215	0.00215	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TAAR6—cervical cancer	0.00215	0.00215	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—WNT5A—cervical cancer	0.00214	0.00214	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TAAR6—cervical cancer	0.00214	0.00214	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—AKAP13—cervical cancer	0.00212	0.00212	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—AKAP13—cervical cancer	0.00199	0.00199	CbGpPWpGaD
Mesoridazine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—cervical cancer	0.00194	0.00194	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—WNT2—cervical cancer	0.00193	0.00193	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.00189	0.00189	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.00189	0.00189	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.00186	0.00186	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.00186	0.00186	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—WNT5A—cervical cancer	0.00186	0.00186	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TAAR6—cervical cancer	0.00185	0.00185	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—WNT5A—cervical cancer	0.00183	0.00183	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TAAR6—cervical cancer	0.00183	0.00183	CbGpPWpGaD
Mesoridazine—DRD3—Circadian rythm related genes—TP53—cervical cancer	0.00173	0.00173	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—WNT5A—cervical cancer	0.00172	0.00172	CbGpPWpGaD
Mesoridazine—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00169	0.00169	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—AKAP13—cervical cancer	0.00169	0.00169	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.00168	0.00168	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.00167	0.00167	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—WNT2—cervical cancer	0.00147	0.00147	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.00147	0.00147	CbGpPWpGaD
Mesoridazine—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00147	0.00147	CbGpPWpGaD
Mesoridazine—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00147	0.00147	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.00147	0.00147	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—WNT5A—cervical cancer	0.00146	0.00146	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.00145	0.00145	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—WNT2—cervical cancer	0.00145	0.00145	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—WNT2—cervical cancer	0.00142	0.00142	CbGpPWpGaD
Mesoridazine—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.00132	0.00132	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.00129	0.00129	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.00127	0.00127	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.00127	0.00127	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—AKAP13—cervical cancer	0.00127	0.00127	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.00127	0.00127	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—AKAP13—cervical cancer	0.00125	0.00125	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—NOTCH2—cervical cancer	0.00121	0.00121	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.00112	0.00112	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.0011	0.0011	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—WNT5A—cervical cancer	0.0011	0.0011	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—WNT5A—cervical cancer	0.00108	0.00108	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—NOTCH2—cervical cancer	0.00103	0.00103	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—HES1—cervical cancer	0.00099	0.00099	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—CA9—cervical cancer	0.000972	0.000972	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.000893	0.000893	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000889	0.000889	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TERT—cervical cancer	0.000867	0.000867	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—HES1—cervical cancer	0.00084	0.00084	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—FGFR3—cervical cancer	0.000796	0.000796	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000784	0.000784	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000772	0.000772	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NOTCH2—cervical cancer	0.00077	0.00077	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NOTCH2—cervical cancer	0.000758	0.000758	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—NOTCH1—cervical cancer	0.000747	0.000747	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TERT—cervical cancer	0.000736	0.000736	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000733	0.000733	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000729	0.000729	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—FGFR3—cervical cancer	0.000676	0.000676	CbGpPWpGaD
Mesoridazine—HTR6—Signaling by GPCR—EGFR—cervical cancer	0.000666	0.000666	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—HES1—cervical cancer	0.000643	0.000643	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TERT—cervical cancer	0.000642	0.000642	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000639	0.000639	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—NOTCH1—cervical cancer	0.000635	0.000635	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—HES1—cervical cancer	0.000633	0.000633	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—HES1—cervical cancer	0.000631	0.000631	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—HES1—cervical cancer	0.000621	0.000621	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—FGFR3—cervical cancer	0.000589	0.000589	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.000586	0.000586	CbGpPWpGaD
Mesoridazine—DRD3—Signaling by GPCR—EGFR—cervical cancer	0.000565	0.000565	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TERT—cervical cancer	0.000564	0.000564	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—MTOR—cervical cancer	0.00056	0.00056	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TERT—cervical cancer	0.000555	0.000555	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TERT—cervical cancer	0.000553	0.000553	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	0.000553	0.000553	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	0.00055	0.00055	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TERT—cervical cancer	0.000544	0.000544	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—FGFR3—cervical cancer	0.000517	0.000517	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CASP3—cervical cancer	0.000515	0.000515	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	0.000509	0.000509	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—FGFR3—cervical cancer	0.000508	0.000508	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—FGFR3—cervical cancer	0.0005	0.0005	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—CTNNB1—cervical cancer	0.000496	0.000496	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling by GPCR—EGFR—cervical cancer	0.000493	0.000493	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	0.00049	0.00049	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	0.000486	0.000486	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	0.000478	0.000478	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—NOTCH1—cervical cancer	0.000477	0.000477	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—MTOR—cervical cancer	0.000475	0.000475	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—NOTCH1—cervical cancer	0.000469	0.000469	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CASP3—cervical cancer	0.000437	0.000437	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—STAT3—cervical cancer	0.000433	0.000433	CbGpPWpGaD
Mesoridazine—DRD2—Signaling by GPCR—EGFR—cervical cancer	0.000433	0.000433	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	0.000426	0.000426	CbGpPWpGaD
Mesoridazine—HRH1—Signaling by GPCR—EGFR—cervical cancer	0.000425	0.000425	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—CTNNB1—cervical cancer	0.000422	0.000422	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling by GPCR—EGFR—cervical cancer	0.000418	0.000418	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—MTOR—cervical cancer	0.000414	0.000414	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—MTOR—cervical cancer	0.000412	0.000412	CbGpPWpGaD
Mesoridazine—CYP2D6—Metabolism—MTHFR—cervical cancer	0.000394	0.000394	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—EGFR—cervical cancer	0.000393	0.000393	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CASP3—cervical cancer	0.000381	0.000381	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CASP3—cervical cancer	0.000379	0.000379	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—STAT3—cervical cancer	0.000367	0.000367	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	0.000367	0.000367	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	0.000365	0.000365	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—MTOR—cervical cancer	0.000364	0.000364	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—MTOR—cervical cancer	0.000358	0.000358	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—MTOR—cervical cancer	0.000357	0.000357	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—MTOR—cervical cancer	0.000351	0.000351	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CASP3—cervical cancer	0.000335	0.000335	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—EGFR—cervical cancer	0.000334	0.000334	CbGpPWpGaD
Mesoridazine—HTR6—Signaling Pathways—TP53—cervical cancer	0.00033	0.00033	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CASP3—cervical cancer	0.000329	0.000329	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CASP3—cervical cancer	0.000329	0.000329	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CASP3—cervical cancer	0.000323	0.000323	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	0.000323	0.000323	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—STAT3—cervical cancer	0.00032	0.00032	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—STAT3—cervical cancer	0.000319	0.000319	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	0.000317	0.000317	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—CTNNB1—cervical cancer	0.000317	0.000317	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—CTNNB1—cervical cancer	0.000312	0.000312	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—EGFR—cervical cancer	0.000291	0.000291	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—EGFR—cervical cancer	0.00029	0.00029	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—STAT3—cervical cancer	0.000281	0.000281	CbGpPWpGaD
Mesoridazine—DRD3—Signaling Pathways—TP53—cervical cancer	0.00028	0.00028	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—STAT3—cervical cancer	0.000277	0.000277	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—STAT3—cervical cancer	0.000276	0.000276	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—STAT3—cervical cancer	0.000272	0.000272	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—EGFR—cervical cancer	0.000256	0.000256	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—EGFR—cervical cancer	0.000251	0.000251	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—EGFR—cervical cancer	0.000251	0.000251	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—EGFR—cervical cancer	0.000247	0.000247	CbGpPWpGaD
Mesoridazine—HTR1A—Signaling Pathways—TP53—cervical cancer	0.000244	0.000244	CbGpPWpGaD
Mesoridazine—HTR2C—Signaling Pathways—TP53—cervical cancer	0.000243	0.000243	CbGpPWpGaD
Mesoridazine—DRD2—Signaling Pathways—TP53—cervical cancer	0.000215	0.000215	CbGpPWpGaD
Mesoridazine—HTR2A—Signaling Pathways—TP53—cervical cancer	0.000211	0.000211	CbGpPWpGaD
Mesoridazine—HRH1—Signaling Pathways—TP53—cervical cancer	0.000211	0.000211	CbGpPWpGaD
Mesoridazine—CHRM2—Signaling Pathways—TP53—cervical cancer	0.000207	0.000207	CbGpPWpGaD
